Screening of choledocholithiasis

The treatment and Screening of choledocholithiasis among the patients with Cholecyslithiasis

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCH-12002783

Enrollment

Unknown

Registered

2012-11-08

Start date

2012-06-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

choledocholithiasis

Interventions

EUS group:EUS

MRCP group:MRCP

Eligibility

Sex/Gender

All

Age

14 Years to 100 Years

Inclusion criteria

Inclusion criteria: Liver function test index of alkaline phosphatase (AKP) or transpeptidase (garma-GT)rised

Exclusion criteria

Exclusion criteria: abdominal ultrasound found choledocholithiasis

Design outcomes

Primary

Measure	Time frame
choledocholithiasis;	—

Countries

China

Contacts

Public ContactLiu Jingang

gengdh@sj-hospital.org+86 18940255035

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026